Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 47

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 47
---
BS
Act.

The costs of being an SEC-reporting public company could result in us being unable to continue as a going concern.

As an SEC-reporting public company, we will be
required to comply with numerous financial reporting and legal requirements, including those pertaining to audits and internal control.
The costs of maintaining a public company reporting requirements could be significant and may preclude us from seeking financing or equity
investment on terms acceptable to us and our stockholders. We estimate these costs to be in excess of $100,000 per year and may be higher
if our business volume or business activity increases significantly. Our current estimate of costs does not include the necessary expenses
associated with compliance, documentation and specific reporting requirements of Section 404 as we will not be subject to the full reporting
requirements of Section 404 until we exceed $700 million in market capitalization or we decide to opt-out of the “emerging growth
company” as defined under the JOBS Act. This exemption is available to us under the JOBS Act or until we have been public for more
than five years.

If our revenues are insufficient or non-existent,
and/or we cannot satisfy many of these costs through the issuance of shares or debt, we may be unable to satisfy these costs in the normal
course of business. This would certainly result in our being unable to continue as a going concern.

Our Common Stock is trading on the OTCID Market, a securities quotation system. An active, liquid trading market for our Common Stock may not develop or be sustained. If and when an active market develops, the price of our common stock may be volatile.

Presently, our Common
Stock is traded on the OTCID tier of OTC Market. There is limited trading of our Common Stock and there is no assurance that an active
market will ever develop. In the absence of an active trading market, investors may have difficulty buying and selling or obtaining market
quotations, market visibility for shares of our Common Stock may be limited, and a lack of visibility for shares of our Common Stock
may have a depressive effect on the market price for shares of our Common Stock. The lack of an active market impairs your ability to
sell your shares at the time you wish to sell them or at a price that you consider reasonable. The lack of an active market may also
reduce the fair market value of your shares. An inactive market may also impair our ability to raise capital to continue to fund operations
by selling shares.

Trading in stocks
quoted on